2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia

BACKGROUND: Increasing evidence suggests that daptomycin (DAP) demonstrates in vitro synergy in combination with other anti-staphylococcal agents, including ceftaroline (CPT) and oxacillin (OXA), against MRSA. Nevertheless, optimal combinations remain undefined. Here, our objective was to compare DA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchard, Jeannette, Jones, Chelsea, Kline, Ellen, Oleksiuk, Louise-Marie, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254037/
http://dx.doi.org/10.1093/ofid/ofy210.2056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254037/
http://dx.doi.org/10.1093/ofid/ofy210.2056

Ejemplares similares